JP2023524596A5 - - Google Patents

Info

Publication number
JP2023524596A5
JP2023524596A5 JP2022567836A JP2022567836A JP2023524596A5 JP 2023524596 A5 JP2023524596 A5 JP 2023524596A5 JP 2022567836 A JP2022567836 A JP 2022567836A JP 2022567836 A JP2022567836 A JP 2022567836A JP 2023524596 A5 JP2023524596 A5 JP 2023524596A5
Authority
JP
Japan
Prior art keywords
disease
independently
alkyl
case
syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022567836A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524596A (ja
JP7739334B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/031386 external-priority patent/WO2021226519A1/en
Publication of JP2023524596A publication Critical patent/JP2023524596A/ja
Publication of JP2023524596A5 publication Critical patent/JP2023524596A5/ja
Priority to JP2025145822A priority Critical patent/JP2026004302A/ja
Application granted granted Critical
Publication of JP7739334B2 publication Critical patent/JP7739334B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022567836A 2020-05-08 2021-05-07 Akt3モジュレーター Active JP7739334B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025145822A JP2026004302A (ja) 2020-05-08 2025-09-03 Akt3モジュレーター

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063021727P 2020-05-08 2020-05-08
US63/021,727 2020-05-08
US202063121077P 2020-12-03 2020-12-03
US63/121,077 2020-12-03
PCT/US2021/031386 WO2021226519A1 (en) 2020-05-08 2021-05-07 Akt3 modulators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025145822A Division JP2026004302A (ja) 2020-05-08 2025-09-03 Akt3モジュレーター

Publications (3)

Publication Number Publication Date
JP2023524596A JP2023524596A (ja) 2023-06-12
JP2023524596A5 true JP2023524596A5 (cg-RX-API-DMAC10.html) 2024-05-16
JP7739334B2 JP7739334B2 (ja) 2025-09-16

Family

ID=78468505

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022567836A Active JP7739334B2 (ja) 2020-05-08 2021-05-07 Akt3モジュレーター
JP2025145822A Pending JP2026004302A (ja) 2020-05-08 2025-09-03 Akt3モジュレーター

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025145822A Pending JP2026004302A (ja) 2020-05-08 2025-09-03 Akt3モジュレーター

Country Status (12)

Country Link
US (1) US20230183226A1 (cg-RX-API-DMAC10.html)
EP (1) EP4146667A4 (cg-RX-API-DMAC10.html)
JP (2) JP7739334B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230025534A (cg-RX-API-DMAC10.html)
CN (1) CN115867562A (cg-RX-API-DMAC10.html)
AU (1) AU2021266786A1 (cg-RX-API-DMAC10.html)
BR (1) BR112022022438A2 (cg-RX-API-DMAC10.html)
CA (1) CA3182275A1 (cg-RX-API-DMAC10.html)
IL (2) IL297599A (cg-RX-API-DMAC10.html)
MX (1) MX2022014022A (cg-RX-API-DMAC10.html)
PH (1) PH12022553032A1 (cg-RX-API-DMAC10.html)
WO (1) WO2021226519A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021212111A1 (en) * 2020-04-17 2021-10-21 Augusta University Research Institute, Inc. Compositions and methods for treating leukemia
CN116217320B (zh) * 2023-03-02 2025-03-04 哈尔滨工业大学(深圳) 一种非均相催化炔烃与叠氮的轴手性Click合成方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US4675189A (en) 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5133974A (en) 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US5407686A (en) 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US20030225273A1 (en) * 2002-03-21 2003-12-04 Michaelides Michael R. Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
US7534423B2 (en) 2003-03-28 2009-05-19 Faron Pharmaceuticals Oy Method for inducing an elevated level of adenosine in an individual
EP2078008A2 (en) * 2006-10-12 2009-07-15 SuperGen, Inc. Quinoline derivatives for modulating dna methylation
CA2678180A1 (en) 2007-02-13 2008-12-04 Northeastern University Methods and compositions for improving immune responses
US7939546B2 (en) * 2007-10-12 2011-05-10 Supergen, Inc. Quinoline derivatives for modulating DNA methylation
US7790746B2 (en) * 2007-10-12 2010-09-07 Supergen, Inc. Quinoline derivatives for modulating DNA methylation
FR2972535B1 (fr) * 2011-03-07 2014-05-02 Crime Scene Technology Trousse de revelation comprenant une tetrazine et un cyanoacrylate, procede de co-fumigation d'une tetrazine et d'un cyanoacrylate
CA2952188A1 (en) * 2014-06-20 2015-12-23 Aurigene Discovery Technologies Limited Substituted indazole compounds as irak4 inhibitors
WO2017039318A1 (en) * 2015-09-01 2017-03-09 Kainos Medicine, Inc. Benzimidazole derivatives for dna methylation inhibitors
US10342868B2 (en) 2016-01-15 2019-07-09 Augusta University Research Institute, Inc. Methods and compositions for inhibiting Akt3
CN106749071B (zh) * 2017-01-10 2019-03-01 江西师范大学 一种芳香类1,2,4,5-四嗪化合物的制备方法
EP3678666B1 (en) * 2017-09-07 2025-07-09 Augusta University Research Institute, Inc. Specific akt3 activator and uses thereof
CN117887659A (zh) * 2018-05-01 2024-04-16 云南济慈再生医学研究院有限公司 一种促进靶细胞向神经细胞分化的方法
BR112022022327A2 (pt) * 2020-05-08 2023-01-03 Georgiamune Llc Moduladores de akt3 e métodos de uso dos mesmos

Similar Documents

Publication Publication Date Title
JP2023525757A5 (cg-RX-API-DMAC10.html)
JP2023524600A5 (cg-RX-API-DMAC10.html)
Mohanty et al. Antibacterial activity of Thiazole and its derivatives: A
AU2018358157B2 (en) Modulators of the integrated stress pathway
CA2672596C (en) Compositions and methods of using (r)-pramipexole
CZ297907B6 (cs) Aminothiazolové deriváty a farmaceutické kompozice s jejich obsahem
CA2972014A1 (en) Fused pyrimidine compounds for the treatment of hiv
JP2024541995A5 (cg-RX-API-DMAC10.html)
HUP0301213A2 (hu) Ciklin dependens kinázok amino-tiazol inhibitorai, ezeket tartalmazó gyógyszerkészítmények, előállításuk és alkalmazásuk
IL297612A (en) Control of an electronic evaporation device
AU2018360850A1 (en) Modulators of the integrated stress pathway
CA3008747A1 (en) Novel compounds
JP2024540107A5 (cg-RX-API-DMAC10.html)
NO20100827L (no) Glukocorticoid-mimetica, fremgangsmater for fremstilling av dem, farmasoytiske blandinger, og anvendelser derav
JP2017520571A5 (cg-RX-API-DMAC10.html)
JP2023525756A5 (cg-RX-API-DMAC10.html)
JP2017532360A5 (cg-RX-API-DMAC10.html)
KR20090055562A (ko) 오로라 a 선택적 억제 작용을 갖는 신규한 아미노피리딘 유도체
NO20034031L (no) Substituerte pyrazol- og tiazolpyrimidiner
JP2022536901A5 (cg-RX-API-DMAC10.html)
JP2026004302A (ja) Akt3モジュレーター
PL348108A1 (en) Bile-acid substituted phenyl alkenoyl guanidines, method for the production thereof, use thereof as medicaments or diagnostic agents and medicaments that contain them
JP2024541994A5 (cg-RX-API-DMAC10.html)
JP2023554391A5 (cg-RX-API-DMAC10.html)
EP2211637A4 (en) METHOD FOR PRODUCING STAINED AND FLAVORED COMPLETE RICE IN A RETORT METHOD